Attovia Therapeutics (ATTO) vs Candel Therapeutics (CADL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Attovia Therapeutics is the larger company by market cap ($744.6 million vs $739.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ATTO | CADL |
|---|---|---|
| Share price | $16.31 | $9.66 |
| Market cap | $744.57M | $739.17M |
| 1-day change | -0.67% | -1.63% |
| YTD return | — | +70.97% |
| 1-year return | — | +53.33% |
| 5-year return | — | -1.73% |
| EPS (TTM) | $-2.74 | $-1.46 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $28.00 | $14.00 |
| 52-week low | $15.48 | $4.35 |
| Distance from 52-week high | -41.75% | -31.00% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +158.74% | +125.16% |
| Average volume | 457.37K | 1.21M |
| Shares outstanding | 45.65M | 76.52M |
| Employees | 44 | 55 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Attovia Therapeutics
ATTO stock →Attovia Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops biotherapeutics for immune-mediated diseases in the United States. The company provides ATTOBODY, a biparatopic biologics platform designed to deliver improved treatments.
Healthcare · Biotechnology · 44 employees
About Candel Therapeutics
CADL stock →Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for cancer patients. It develops CAN-2409, which is in Phase 2a clinical trials for the treatment of prostate cancer; and Phase 2a clinical trials for the treatment of non-small cell lung cancer (NSCLC).
Healthcare · Biotechnology · 55 employees
ATTO vs CADL FAQ
Which is bigger, Attovia Therapeutics or Candel Therapeutics?
Attovia Therapeutics (ATTO) is larger, with a market capitalization of $744.57M compared with $739.17M for Candel Therapeutics (CADL).
Are Attovia Therapeutics and Candel Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.